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ABSTRACT

Background and objectives: Among placental mammals, females undergo immunological shifts during
pregnancy to accommodate the fetus (i.e. fetal tolerance). Fetal tolerance has primarily been characterized within post-industrial populations experiencing evolutionarily novel conditions (e.g. reduced
pathogen exposure), which may shape maternal response to fetal antigens. This study investigates
how ecological conditions affect maternal immune status during pregnancy by comparing the direction
and magnitude of immunological changes associated with each trimester among the Tsimane (a subsistence population subjected to high pathogen load) and women in the USA.
Methodology: Data from the Tsimane Health and Life History Project (N ¼ 935) and the National
Health and Nutrition Examination Survey (N ¼ 1395) were used to estimate population-specific effects
of trimester on differential leukocyte count and C-reactive protein (CRP), a marker of systemic
inflammation.
Results: In both populations, pregnancy was associated with increased neutrophil prevalence, reduced
lymphocyte and eosinophil count and elevated CRP. Compared to their US counterparts, pregnant
Tsimane women exhibited elevated lymphocyte and eosinophil counts, fewer neutrophils and monocytes and lower CRP. Total leukocyte count remained high and unchanged among pregnant Tsimane
women while pregnant US women exhibited substantially elevated counts, resulting in overlapping
leukocyte prevalence among all third-trimester individuals.
Conclusions and implications: Our findings indicate that ecological conditions shape non-pregnant
immune baselines and the magnitude of immunological shifts during pregnancy via developmental
constraints and current trade-offs. Future research should investigate how such flexibility impacts
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Hové et al. |

Flexibility of fetal tolerance

115

maternal health and disease susceptibility, particularly the degree to which chronic pathogen exposure might dampen inflammatory response to fetal antigens.
Lay Summary: This study compares immunological changes associated with pregnancy between the Tsimane (an Amazonian subsistence population) and individuals in the USA. Results suggest that while pregnancy enhances non-specific defenses and dampens both
antigen-specific immunity and parasite/allergy response, ecological conditions strongly influence immune baselines and the magnitude
of shifts during gestation.
K E Y W O R D S : reproductive ecology; fetal tolerance; ecological immunology; Tsimane

INTRODUCTION
Among placental mammals, female reproduction requires hosting
genetically non-identical offspring throughout gestation without
rejecting fetal tissue—a phenomenon termed fetal tolerance [1]. In
humans (as well as chimpanzees and gorillas), placentation is particularly invasive [2, 3] and fetal tolerance requires systemic
changes in maternal immune function that alter susceptibility to
certain infections and autoimmune disorders [4–7]. To date, fetal
tolerance has been studied primarily in high-income post-industrial countries, such as the USA and the UK, where epidemiological transitions over the past several centuries have largely curbed
exposure to numerous parasites, pathogens and microbes otherwise abundant throughout human history prior to industrialization
[8, 9]. Such microbial deprivation lowers overall infectious disease
mortality but provides fewer opportunities for immune calibration,
paving the way for immunological hypersensitivity to nonpathogenic stimuli and development of myriad chronic inflammatory disorders (e.g. allergy, rheumatoid arthritis) common across
industrialized populations [10]. The potential effects of impaired
immune calibration on maternal responses to fetal antigens likely
interact with other common and evolutionarily novel aspects of
post-industrial societies, such as elevated rates of obesity (a
chronic inflammatory state) [11] and low parity (which results in
less ‘exposure’ to fetal antigens over time). Considering the current characterization of fetal tolerance is primarily derived from
populations experiencing such ecological conditions, understanding of how fetal tolerance is shaped by environments more closely
resembling those experienced throughout most of human evolution and by many women alive today is limited.
From both an evolutionary perspective and a public health standpoint, there is a pressing need to examine the effect of pregnancy
on maternal immunity across diverse environments, particularly
those characterized by elevated infection risk. To this end, this study
estimates and compares the effect of pregnancy on differential
leukocyte count and C-reactive protein (CRP) concentration among
Tsimane women, a natural-fertility subsistence population inhabiting a pathogen-rich environment, and women in the USA (Table 1).

Maternal immune changes during pregnancy
In humans and other mammalian species with haemochorial
placentation, gestation results in exposure to both fetal cells [12]

and cell-free fetal DNA [13], prompting systemic recalibration of
maternal immune function and changes in maternal disease
susceptibility [14]. During pregnancy, women are generally
more vulnerable to intracellular pathogens [4] but exhibit elevated resistance to extracellular microbes [5]. Pregnancy also
exerts contrasting effects on autoimmunity: certain autoimmune diseases, such as rheumatoid arthritis, temporarily resolve during gestation [15] while others worsen [16]. These
alterations in disease susceptibility have been linked to quantitative shifts in immune components, though the underlying
causal pathways are only partially elucidated. Pregnancy is often
described as a state of regulated inflammation [17] and is consistently marked by a rise in the total number of circulating leukocytes [18], primarily due to expansion of neutrophils and
monocytes [19]. Neutrophils and monocytes are phagocytic
cells that induce inflammatory activation and strengthen resistance to extracellular infections, but are also implicated in the
etiology of autoimmune diseases [20]
and deleterious
inflammation-mediated conditions, such as preterm birth [21].
Total lymphocyte counts are consistently reduced during pregnancy, primarily due to fewer circulating cytotoxic lymphocytes
capable of directly recognizing and targeting fetal antigens [22,
23]. Conversely, proliferation of regulatory lymphocytes is
heightened [24], further moderating the response to fetal antigens. Eosinophils mediate parasitic and allergic responses and
are often reduced among pregnant women [25], though the role
of pregnancy-induced eosinopenia is relatively understudied.
Taken together, these patterns (based primarily on crosssectional studies of women in high-income industrialized countries) suggest that pregnancy induces heavier reliance on nonspecific defenses and down-regulation of antigen-specific immunity and immune components involved in allergy/parasite
response, thereby facilitating fetal tolerance while preserving
general pathogen defense.

Immune function among the Tsimane
The Tsimane inhabit the Bolivian neo-tropics, an environment
rich in biodiversity and home to myriad infectious agents. Due
to varied and chronic exposure, infections (largely respiratory
and gastrointestinal) are the primary drivers of morbidity and
mortality among the Tsimane, while allergies, atopy and

116
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Table 1. General descriptions of immunological biomarkers used in this study
Total leukocytes
Lymphocytes
Neutrophils
Monocytes
Eosinophils
Basophils
CRP

The total number of nucleated immune cells circulating in the blood, also known as WBC count.
A heterogenous group of cells identified based on the presence of CD45 receptors. Made up of T,
B and Natural Killer cells that together mediate antigen-specific immunity.
Abundant phagocytic granulocytes that respond to extracellular and fungal infection, prime the adaptive response and promote inflammation.
Phagocytic granulocytes, similar in function to neutrophils but shorter-lived and less prevalent in the
blood. Migrate to sites of infection where they differentiate into tissue-specific macrophages.
Granulocytes involved in parasite response and allergy. Chronically elevated in populations where
parasite exposure is high.
A rare type of granulocyte involved in inflammation and parasite response.
Non-specific acute-phase reactant released by the liver in response to inflammation.

autoimmune diseases are rare [26]. At any given time, the majority of Tsimane individuals are infected with at least one species of helminth, and over a third are infected with giardia [27].
Furthermore, Tsimane women have restricted access to contraception and the average total fertility rate is nine births per
woman [28]. On average, the Tsimane exhibit developmental
trajectories in which energetic investment is preferentially
shunted into overall immune function, resulting in higher resting metabolic rate and total energy expenditure [29], reduced
growth [30] and elevated baseline levels of most immunological
parameters compared to Western clinical standards [31].
Average leukocyte counts are higher among the Tsimane, due
to more circulating lymphocytes, neutrophils and eosinophils.
On average, eosinophil counts are 7 higher among Tsimane
individuals compared to current Western clinical standards,
presumably reflecting chronic exposure to multicellular parasites, whereas basophil and monocyte counts are lower and
might reflect greater recruitment of these cells out of circulation
into localized sites of infection [31]. Acute inflammation, measured by CRP, is roughly comparable between US and Tsimane
adults aged 18–49, although the etiology differs: among the
Tsimane, inflammation is primarily driven by infection, whereas
obesity, cigarette smoking and chronic inflammatory disorders
(e.g. Type 2 diabetes) are larger contributors to low-grade
chronic inflammation in the US population [31].

Predictions
Considering how the immunological demands of fetal tolerance
and pathogen defense may collide in the pathogen-rich, resource-restricted environment currently inhabited by the
Tsimane, we suggest three possible scenarios. Scenario 1:
Tsimane women may experience less pregnancy-induced
changes in immune function than do US women, potentially
compromising fetal tolerance to maintain pathogen resistance.
In this case, we would expect that the estimated effects of

pregnancy on leukocyte (i.e. WBC) differential and CRP would
be comparatively smaller in magnitude among the Tsimane.
Scenario 2: Tsimane women may experience similar changes in
immunity to women in less pathogenic conditions, thus experiencing greater infection risk at the cost of maintaining fetal tolerance. Under this scenario, both the direction and magnitude
of the estimated effects of pregnancy on immune status should
be comparable between populations. Scenario 3: Tsimane
women may compensate for the dual burden of fetal tolerance
and infection by preferentially elevating defenses which are less
likely to specifically target fetal antigens (e.g. non-specific immunity). In this context, pregnancy should correspond to a disproportionate increase in markers of non-specific immunity
(e.g. neutrophils, monocytes and CRP) compared to degree of
down-regulation of antigen-specific immune function (e.g. total
lymphocyte count).

METHODOLOGY
Tsimane health and life history project dataset
Mixed cross-sectional and longitudinal data were collected from
2004 to 2014 as part of the ongoing Tsimane Health and Life
History Project (THLHP; http://tsimane.anth.ucsb.edu/index.
html, (13 July 2020, date last accessed)) [27, 31–33]. Pregnancy
status was determined during medical visits based on date of
last menses, with urinary pregnancy tests administered by the
physician when pregnancy was suspected. Pregnancies were
cross-validated against subsequent annual demographic and
census interviews that ascertained children’s birth dates, permitting detection of pregnancies occurring between medical visits and pregnancies that went undetected during previous
physician examinations [33].
Venous blood drawn into heparinized vacutainers was analyzed immediately after collection. Total leukocyte counts were
determined with a QBC Autoread Plus dry hematology system
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(QBC Diagnostics) and relative fractions of neutrophils, eosinophils, lymphocytes, basophils and monocytes were determined
manually by microscopy with a hemocytometer. Blood drawn
into serum vacutainers was allowed to clot and then centrifuged
to separate serum, which was frozen in liquid nitrogen and then
transported on dry ice for analysis at the University of
California, Santa Barbara (UCSB). Serum samples were then
analyzed to determine CRP concentration at the UCSB Human
Biodemography lab via enzyme immunoassay (ELISA) [34],
using a protocol validated against the same University of
Washington lab responsible for NHANES data analyses [31].
For this study, the THLHP dataset included pregnant and
non-pregnant cycling women aged 18–45 years with total and
differential leukocyte count (WBC) and/or CRP concentration.
Non-pregnant women who were not regularly menstruating due
to either lactational amenorrhea or menopause were excluded
from analyses. Given these inclusion criteria, the initial THLHP
sample contained 1198 observations (cycling N ¼ 942; pregnant
N ¼ 256). The number of pregnant women sampled was lower
than the number of cycling women, and pregnant participants
were, on average, younger than cycling women. Based on previously reported Tsimane interbirth intervals and THLHP oversampling of people over age 40 during some rounds of data
collection, this initial sampling distribution roughly followed the
expected 3:1 ratio of cycling to pregnant participants. To address potential sampling biases, we randomly selected a subset
of cycling women from the initial dataset with an agedistribution matching that of the pregnant subset. We did this
by dividing the pregnant subset into 6-year age groups and
using the sample function in R to pick a proportional sample of
cycling women from each age bracket. Since not all individuals
had recorded data for both CRP and WBC, we conducted this
age-matching process separately for participants with complete
WBC differential data and those with CRP data. Across the final
aggregated dataset used for this study, slightly more individuals
were sampled during the second and third trimester compared
to the first, although not more than would be expected by
chance (v2 ¼ 3.66, df ¼ 2, P > 0.1). Pregnant and cycling
Tsimane women exhibited comparable body mass index (BMI)
(t ¼ 0.73, df ¼ 497.01, P-value ¼ 0.46), while median parity
(i.e. number of live births) was higher among pregnant women
(t ¼ 3.20, df ¼ 454.55, P-value <0.01).
Although median parity was comparatively lower within the
cycling sample, this was likely due to the mixed cross-sectional
and longitudinal nature of the THLHP collection schedule rather than disproportionate sampling of individuals with undiagnosed fertility issues. Based on the ratio of Tsimane women
experiencing lactational amenorrhea to those who are currently
pregnant (at any given age), lactational amenorrhea usually
lasts between 12 and 14 months. Considering the average interbirth interval in this population is 30 months [28], these
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estimates indicate that most Tsimane women experience 7 to
9 months of regular cycling between each pregnancy. In our entire sample of non-pregnant cycling Tsimane women, the median number of recorded live births was 4 (range ¼ 0–11),
providing further evidence that by-and-large these individuals
were simply in-between pregnancies when these particular data
were collected. Only 88 out of 727 total observations in the
cycling sample belonged to nulliparous individuals, and of
these the majority belonged to individuals who were under the
age of 25. In total, only 3% of non-pregnant regularly cycling
Tsimane women in our sample were both nulliparous and over
the age 25, suggesting that our findings are not skewed by disproportionate sampling of women with undiagnosed infertility.
For complete descriptive statistics, see Table 2.

NHANES dataset
We compiled data from NHANES (2003–16) (https://wwwn.
cdc.gov/nchs/nhanes/, (14 July 2020, date last accessed)), limiting our sample to pregnant and cycling women between ages
18 and 45 years with complete data on WBC differential and/or
CRP concentration. To ensure as comparable of a selection process as possible between THLHP and NHANES samples, individuals in the NHANES dataset were included in the cycling
group if they were not pregnant or breastfeeding at the time of
the study, reported having regular menstrual cycles throughout
the last year, and were not currently using hormonal contraception. No exclusions were based on medical diagnoses. CRP was
measured using nephelometry, while total and differential
leukocyte counts were measured using the Coulter method. All
participants in the NHANES dataset were measured only once.
According to these inclusion criteria and dataset characteristics,
the initial NHANES dataset selected for this study contained
1652 observations (cycling N ¼ 1375; pregnant N ¼ 277). The
same method used to age-match groups within the THLHP
dataset was utilized to age-match cycling and pregnant subsets
within the NHANES dataset, for both WBC differential and CRP
subsamples. Pregnancy was determined by participant report or
urine test at the time of exam, which may explain why women in
their first trimester were significantly under-sampled relative to
women in later pregnancy (v2 ¼ 25.15, df ¼ 2, P < 0.001).
Overall, pregnant US women exhibited higher BMI (t ¼ 2.59,
df ¼ 490.17, P-value <0.01) and lower median parity (t ¼
13.91, df ¼ 487.45, P-value <0.001) than non-pregnant
women. For complete descriptive statistics, see Table 2.
Given population-level differences in age (t ¼ 13.73, df ¼
1460.40, P-value <0.001), BMI (t ¼ 18.41, df ¼ 1957.40, P-value
<0.001) and parity (t ¼ 36.27, df ¼ 1107.40, P-value <0.001),
we did not attempt to match sampling distributions across populations, as this would have substantially reduced our overall
sample for analysis. Instead, we controlled for age, BMI and
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Table 2. Descriptive statistics indicating median value and range (in parentheses) for age, BMI and
parity (number of live births), as well as number of repeat samples and total sample size for each population, reproductive status and data subset (leukocyte differential/CRP)
Subset

Population

Descriptive

Cycling

T1

T2

T3

Leukocyte differential

NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP
NHANES
THLHP

Age

27 (20–44)
32 (18–45)
26 (15–73)
24 (17–36)
0 (0, 3)
4 (0, 10)
0
149
1060 (71.41%
662 (13.14%
27 (20–45)
38 (18–45)
26 (15–73)
24 (19–37)
0 (0, 3)
6 (0, 11)
0
0
476 (69.75%
65 (10.77%
1536
727

25 (18–41)
32 (18–45)
26 (17–67)
23 (17–31)
2 (0, 3)
6 (1, 11)
0
1
52
70
25 (18–41)
38 (21–44)
26 (17–67)
22 (21–29)
2 (0, 3)
7 (2, 12)
0
0
53
10
105
80

27 (19–40)
29 (18–45)
27 (19–57)
23 (19–37)
1 (0, 3)
5 (0, 11)
0
3
107
94
27 (19–43)
37 (22–43)
27 (19–57)
25 (22–32)
1 (0, 3)
8 (3, 10)
0
0
113
11
220
105

28 (18–39)
34 (18–45)
30 (21–57)
25 (19–33)
2 (1, 3)
6 (1, 11)
0
6
108
91
28 (18–39)
40 (19–42)
30 (21–57)
26 (23–30)
1 (1, 3)
8 (1, 12)
0
0
110
8
218
99

CRP

Total

BMI
Parity
RM
N
Age
BMI
Parity
RM
N
N

np)
np)

np)
np)

‘% np’ indicates percent of nulliparous individuals within sample.
T1, trimester 1; T2, trimester 2; T3, trimester 3.

parity in all statistical models. The final dataset is available at
https://doi.org/10.25349/D94C77, (14 July 2020, date last
accessed).

Statistical analyses
All analyses were conducted in R 3.6.2 (https://cran.r-project.
org/, (14 July 2020, date last accessed)) using the brms package
[35]. For each outcome variable, we estimated the populationspecific effects of reproductive status (i.e. non-pregnant cycling,
trimester 1, trimester 2 or trimester 3), adjusting for fixedeffects of age, BMI and parity and, when applicable, a random
effect of participant ID, to account for repeated measures per
participant in the mixed cross-sectional and longitudinal
THLHP sample. Due to population-specific differences in immune marker distributions, THLHP and NHANES eosinophil
count, monocyte count and monocyte proportion were modeled
separately using discrete priors and different distribution families. Among the Tsimane, raw eosinophil counts were logtransformed and then estimated using a Gaussian model, while

eosinophil counts among US women followed a negative binomial distribution and were modeled as such. Monocyte counts
among Tsimane women included excess zeroes and were therefore approximated using a zero-inflated Poisson model, while
monocyte counts among US women were log-transformed and
estimated using a Gaussian distribution. All other biomarkers
were distributed similarly across populations and were therefore modeled together, with population as a model term and trimester:population as the interaction term. Gaussian models
were used to estimate all log-transformed measures following a
normal distribution (i.e. CRP, total leukocyte count, neutrophil
count and proportion, lymphocyte count and proportion) while
zero-inflated Poisson models were used for biomarkers with excess zero counts (i.e. basophil count). In both populations, eosinophil percentage was log-left-skewed and was modeled
using a skew-normal distribution following log-transformation.
Median values and 5th and 95th quantiles for all outcome
variables in each reproductive state were estimated using age-,
parity- and BMI-standardized posterior population distributions
(Table 3). Delta values, both between populations for each

NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D
NHANES
THLHP
D

Total leukocytes (cells/ml)

Neutrophils (cells/ml)

Lymphocytes (cells/ml)

Eosinophils (cells/ml)

Monocytes (cells/ml)

% Monocytes

% Eosinophils

% Lymphocytes

% Neutrophil

Basophils (cells/ml)

Population

Measure
7013
9392
2439
34.8%
3914
4866
872
22.0%
2178
2768
568
26.1%
125
1176
1016
555.1%
493
0
457
0
0
0
56.4%
51.1%
5.2%
30.7%
28.8%
2.0%
3.2%
15.1%
11.5%
7.5%
0.0%
7.2%

Cycling
(4473, 10 885)
(6112, 14 788)
(2182, 2690)
(30.8%, 38.6%)
(2156, 7080)
(2728, 8556)
(704, 1049)
(17.5%, 26.8%)
(1313, 3606)
(1678, 4603)
(479, 659)
(21.8%, 30.5%)
(10, 520)
(249, 5669)
(914, 1139)
(490.9%, 630.7%)
(287, 837)
(0, 136)
(814, 224)
(0, 113)
(0, 0)
(113, 0)
(41.9%, 76.7%)
(38.0%, 68.9%)
(6.3%, 4.1%)
(20.1%, 47.4%)
(19.2%, 43.9%)
(2.9%, 1.1%)
(1.2%, 7.1%)
(5.7%, 33.3%)
(10.8%, 12.2%)
(4.9%, 11.6%)
(0.0%, 2.0%)
(11.3%, 4.2%)

8154
9733
1661
20.5%
5158
5265
83
1.6%
1980
2694
715
36.5%
133
1315
1095
572.9%
537
0
494
0
0
0
63.9%
53.9%
9.8%
24.4%
27.3%
3.1%
2.8%
14.5%
11.2%
7.2%
0.0%
6.9%

(5172, 12 769)
(6311, 15 432)
(894, 2408)
(10.6%, 31.1%)
(2886, 9356)
(2946, 9432)
(488, 673)
(8.8%, 14.0%)
(1184, 3282)
(1599, 4501)
(489, 935)
(23.7%, 49.8%)
(11, 535)
(281, 5909)
(856, 1404)
(400.7%, 826.9%)
(323, 918)
(0, 168)
(892, 235)
(0, 114)
(0, 0)
(114, 0)
(47.6%, 84.9%)
(40.4%, 72.4%)
(13.3%, 6.7%)
(15.9%, 36.5%)
(17.5%, 41.8%)
(0.9%, 5.3%)
(1.1%, 6.2%)
(5.4%, 32.7%)
(9.7%, 12.8%)
(4.6%, 11.2%)
(0.0%, 2.0%)
(10.9%, 3.9%)

Trimester 1
9132
9248
135
1.5%
6602
5762
758
11.6%
1836
2159
324
17.7%
106
947
784
514.3%
550
0
516
0
0
0
71.0%
61.8%
9.2%
19.6%
23.3%
3.2%
2.4%
11.8%
9.0%
6.4%
0.0%
6.9%

(5833, 14 450)
(6015, 14 644)
(441, 755)
(4.7%, 8.4%)
(3736, 11 741)
(3191, 10 029)
(1289, 260)
(19.0%, 4.1%)
(1080, 3092)
(1290, 3600)
(165, 486)
(8.6%, 27.3%)
(9, 447)
(196, 4268)
(629, 973)
(388.5%, 680.4%)
(319, 936)
(0, 92)
(900, 287)
(0, 118)
(0, 0)
(114, 0)
(52.7%, 93.9%)
(45.7%, 82.6%)
(12.1%, 6.4%)
(12.7%, 30.8%)
(15.0%, 35.8%)
(1.8%, 4.7%)
(0.9%, 5.4%)
(4.4%, 26.5%)
(8.0%, 10.2%)
(4.1%, 9.9%)
(0.0%, 2.0%)
(11.0%, 4.1%)

Trimester 2

Table 3. Leukocyte counts, leukocyte proportions and CRP concentration by population and reproductive status

9056
9109
44
0.5%
6439
5855
652
10.1%
1704
2169
480
28.5%
104
695
553
379.3%
609
0
577
0
0
0
71.8%
64.4%
7.3%
18.6%
23.6%
5.2%
2.3%
9.5%
6.8%
7.2%
0.0%
6.9%
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(5825, 14 338)
(5869, 14 353)
(563, 627)
(6.0%, 7.1%)
(3593, 11 821)
(3248, 10 507)
(1170, 107)
(17.4%, 1.7%)
(1020, 2900)
(1296, 3727)
(329, 637)
(18.9%, 38.8%)
(10, 419)
(152, 3200)
(432, 703)
(272.3%, 515.4%)
(355, 1020)
(0, 126)
(981, 299)
(0, 112)
(0, 0)
(112, 0)
(53.6%, 95.6%)
(47.7%, 86.5%)
(10.3%, 4.2%)
(12.3%, 29.1%)
(15.2%, 36.8%)
(3.8%, 6.7%)
(0.9%, 5.4%)
(3.5%, 20.8%)
(5.9%, 7.7%)
(4.7%, 11.2%)
(0.0%, 2.0%)
(11.1%, 4.0%)

Trimester 3
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0.0%
0.0%
0.0%
1.48
1.32
0.13
8.4%
CRP (mg/l)

NHANES
THLHP
D
NHANES
THLHP
D
% Basophils

Cycling
Population
Measure

For all measures, reported absolute values are the estimated median, 5th and 95th percentiles of the posterior population distributions, standardized by age, BMI and parity. Estimated median,
5th and 95th percentiles for delta values (D) represent the calculated difference between standardized parameter distributions, with the exception of monocytes and basophils, which were calculated using the difference between posterior population distributions to include excess zero values (and therefore produce larger confidence intervals).

0.0%
0.0%
0.0%
4.03
3.92
0.11
2.8%

(0.0%, 1.0%)
(0.0%, 0.0%)
(1.0%, 0.0%)
(0.70, 23.57)
(0.60, 24.56)
(2.30, 3.34)
(52.7%, 91.7%)

0.0%
0.0%
0.0%
5.04
3.91
1.04
20.2%

(0.0%, 1.0%)
(0.0%, 0.0%)
(1.0%, 0.0%)
(0.87, 30.26)
(0.65, 24.68)
(3.00, 2.25)
(56.0%, 46.2%)

0.0%
0.0%
0.0%
3.47
1.67
1.89
54.1%

(0.0%, 1.0%)
(0.0%, 0.0%)
(1.0%, 0.0%)
(0.59, 21.19)
(0.24, 9.68)
(2.85, 0.25)
(75.8%, 6.7%)

Evolution, Medicine, and Public Health

(0.0%, 2.0%)
(0.0%, 0.0%)
(2.0%, 0.0%)
(0.25, 8.08)
(0.24, 7.64)
(0.51, 0.40)
(33.1%, 27.4%)

Trimester 1

Trimester 2

Trimester 3
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reproductive state (Table 3) and between reproductive states
within each population (Table 4), were calculated as the difference between standardized posterior parameter distributions,
with the exception of basophil and monocyte counts and proportions, which were calculated as the difference between
standardized posterior population distributions to account for
excess zeros. When reporting results, posterior distributions on
log scales were exponentiated to return them to the linear scale
of the original measures. Estimated fixed-effects of age, parity
and BMI for each outcome variable are provided in Table 5.

RESULTS
Total leukocyte counts overlap among second and third
trimester Tsimane and US women, despite Tsimane
women having substantially elevated non-pregnant
baselines
Non-pregnant cycling Tsimane women had, on average, 34.8%
(CI ¼ 30.8%, 38.6%) or 2439 cells/ml (CI ¼ 2182, 2690) more
circulating leukocytes than their US peers—reflecting elevated
baseline immune activation (Table 3). Among US women, first,
second and third trimester leukocyte counts were increased
over non-pregnant baseline by 15.1% (CI ¼ 7.8%, 22.8%),
31.1% (CI ¼ 24.9%, 37.1%) and 29.2% (CI ¼ 23.2%, 34.9%), respectively (Table 4). In contrast, there was no appreciable variation in leukocyte count among Tsimane women attributable to
reproductive state. As a result, leukocyte counts did not differ
significantly between Tsimane and US women in the second
and third trimester (Table 3 and Fig. 1).

Pregnant women in both populations exhibit elevated
neutrophil counts, reduced lymphocytes and fewer
eosinophils than non-pregnant women, but the magnitude
of these differences varies by trimester and population
Neutrophils. Neutrophil counts among cycling Tsimane
women were 22.0% (CI ¼ 17.5%, 26.8%) or 872 cells/ml (CI ¼
704, 1049) higher than cycling US women (Table 3). Within the
US sample, women in the first, second and third trimester possessed neutrophil counts that were elevated over non-pregnant
baseline by 30.3% (CI ¼ 19.5%, 41.3%), 65.0% (CI ¼ 55.5%,
74.4%) and 63.0% (CI ¼ 53.7%, 72.9%), respectively (Table 4).
Pregnancy was also associated with elevated neutrophil counts
among Tsimane women, although the magnitude of this relationship was relatively attenuated: neutrophil counts were
increased by 8.4% (CI ¼ 0.3%, 16.7%), 19.3% (CI ¼ 11.6%,
27.5%) and 20.5% (CI ¼ 12.5%, 28.4%) among first, second
and third trimester Tsimane women (Table 4). Consequently,
average neutrophil counts among second and third trimester
Tsimane women were 758 (CI ¼ 260, 1289) and 652 (CI ¼ 107,
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Table 4. Model-estimated delta values (D) for leukocyte counts and CRP, by trimester and population
Measure

Population

Total leukocytes NHANES
THLHP
Neutrophils

NHANES
THLHP

Lymphocytes

NHANES
THLHP

Eosinophils

NHANES
THLHP

Monocytes

Basophils
CRP

NHANES
THLHP
NHANES
THLHP
NHANES
THLHP

Unit

T1–cycling D

cells/ml
1058 (552, 1591)
%
15.1% (7.8%, 22.8%)
cells/ml
285 (277, 838)
%
3.0% (2.9%, 8.9%)
cells/ml
1203 (781, 1637)
%
30.3% (19.5%, 41.3%)
cells/ml
410 (13, 815)
%
8.4% (0.3%, 16.7%)
cells/ml
219 (348, 78)
%
10.0% (15.9%, 3.6%)
cells/ml
73 (254, 101)
%
2.7% (9.2%, 3.7%)
cells/ml
8 (31, 55)
%
4.2% (17.0%, 30.3%)
cells/ml
87 (142, 364)
%
7.2% (11.9%, 30.1%)
cells/ml
45 (4, 85)
%
9.0% (0.9%, 17.3%)
cells/ml
0 (132, 164)
cells/ml
0 (110, 110)
cells/ml
0 (0, 0)
mg/l
2.49 (1.61, 3.54)
%
169.0% (105.9%, 244.7%)
mg/l
2.45 (0.67, 5.85)
%
180.7% (46.1%, 436.6%)

T2–cycling D

T3–cycling D

2183
31.1%
121
1.3%
2580
65.0%
934
19.3%
343
15.7%
584
21.3%
31
17.0%
264
22.0%
49
10.0%
0
0
0
3.66
247.2%
2.73
199.3%

2048
29.2%
350
3.7%
2500
63.0%
989
20.5%
497
22.8%
580
21.2%
37
19.8%
499
41.7%
105
21.2%
0
0
0
2.04
137.7%
0.26
19.1%

(1756, 2594)
(24.9%, 37.1%)
(596, 364)
(6.3%, 3.9%)
(2210, 2941)
(55.5%, 74.4%)
(561, 1319)
(11.6%, 27.5%)
(441, 238)
(20.1%, 11.0%)
(717, 455)
(25.9%, 16.7%)
(55, 4)
(29.5%, 2.1%)
(421, 93)
(34.3%, 7.7%)
(20, 81)
(4.0%, 16.5%)
(133, 89)
(110, 115)
(0, 0)
(2.81, 4.62)
(184.6%, 318.0%)
(0.95, 5.84)
(65.1%, 447.3%)

(1641, 2448)
(23.2%, 34.9%)
(805, 118)
(8.5%, 1.3%)
(2141, 2886)
(53.7%, 72.9%)
(613, 1372)
(12.5%, 28.4%)
(585, 402)
(26.7%, 18.6%)
(705, 448)
(25.5%, 16.5%)
(60, 9)
(32.4%, 5.0%)
(635, 353)
(51.1%, 30.3%)
(72, 138)
(14.6%, 28.1%)
(133, 122)
(110, 108)
(0, 0)
(1.50, 2.66)
(98.0%, 184.2%)
(0.58, 1.80)
(38.2%, 138.8%)

For each trimester, delta was calculated as the difference from non-pregnant cycling. Estimated median, 5th and 95th percentiles for delta values were
estimated as the difference between parameter distributions, with the exception of THLHP monocytes and NHANES and THLHP basophils, which
were calculated using the difference between posterior population distributions to include excess zero values.

1170) cells/ml lower than those exhibited by US women (Table 3
and Fig. 1).

Lymphocytes. Lymphocyte

counts among non-pregnant
Tsimane women were 26.1% (CI ¼ 21.8%, 30.5%) or 568 cells/
ml (CI ¼ 479, 659) greater than those observed among cycling
US women (Table 3). Within the US sample, first, second and
third trimester lymphocyte counts were reduced by 10.0% (CI ¼
3.6%, 15.9%), 15.7% (CI ¼ 11.0%, 20.1%) and 22.8% (CI ¼
18.6%, 26.7%) compared to non-pregnant baselines (Table 4).
Among Tsimane women, there was also a negative relationship
between trimester and lymphocyte count: second and third trimester lymphocyte counts were reduced by 21.3% (CI ¼ 16.7%,
25.9%) and 21.2% (CI ¼ 16.5%, 25.5%), respectively (Table 4
and Fig. 1).

Eosinophils. Eosinophil counts among cycling Tsimane
women were 555.1% (CI ¼ 490.9%, 630.7%) or 1016 cells/ml

(CI ¼ 914, 1139) higher than cycling women in the USA
(Table 3). Among US women, there was a negative relationship
between eosinophil count and pregnancy progression, with
counts unchanged in the first trimester, but reduced by 17.0%
(CI ¼ 2.1%, 29.5%) in the second trimester and 19.8% (CI ¼
5.0%, 32.4%) in the third trimester (Table 4). Among Tsimane
women, first trimester eosinophil counts did not significantly
differ from cycling, while second and third trimester counts
were 22.0% (CI ¼ 7.7%, 34.3%) and 41.7% (CI ¼ 30.3%,
51.1%) lower than non-pregnant baseline, respectively (Table 4
and Fig. 1). Regardless of these greater percent reductions from
cycling, third trimester eosinophils remained 379.3% (CI ¼
272.3%, 515.4%) higher in Tsimane women than US women.

Monocytes. Among Tsimane women, monocyte counts did
not vary by reproductive state and remained consistently lower
than those among US women (Table 3). Within the US sample,
monocyte counts in the first, second and third trimester counts
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| Hové et al.

Evolution, Medicine, and Public Health

Table 5. Median and 5% and 95% confidence intervals (in parentheses) for the estimated fixed-effects
of age, BMI and parity for all models
Measure

Units

Age

Total leukocytes
Neutrophils
Lymphocytes
Eosinophils (THLHP)
Eosinophils (NHANES)
Monocytes (THLHP)
Monocytes (NHANES)
Basophils
% Neutrophils
% Lymphocytes
% Eosinophils
% Monocytes (NHANES)
% Monocytes (THLHP)
% Basophils
CRP

ln (cells/ml)
ln (cells/ml)
ln (cells/ml)
ln (cells/ml)
cells/ml
cells/ml
ln (cells/ml)
cells/ml
ln (% cells/ml)
ln (% cells/ml)
ln (% cells/ml)
ln (% cells/ml)
% cells/ml
% cells/ml
ln (mg/l)

0.001
0.001
0.003
0.014
0.008
0.022
0.001
0.007
0.000
0.002
0.001
0.001
0.020
0.011
0.000

BMI
(0.003, 0.001)
(0.003, 0.001)
(0.005, 0.001)
(0.004, 0.024)
(0.017, 0.001)
(0.024, 0.020)
(0.004, 0.002)
(0.006, 0.009)
(0.001, 0.001)
(0.004, 0.000)
(0.002, 0.005)
(0.004, 0.001)
(0.002, 0.038)
(0.004, 0.025)
(0.012, 0.011)

were increasingly elevated above cycling baseline by 9.0% (CI ¼
0.9%, 17.3%), 10.0% (CI ¼ 4.0%, 16.5%) and 21.2% (CI ¼
14.6%, 28.1%) (Table 4 and Fig. 1).

Basophils. In both populations, basophil count remained low
and did not vary by reproductive state (Tables 3 and 4; Fig. 1).

Population-specific differences in immune cell counts
produce variation in leukocyte proportions
Among cycling Tsimane women, total leukocyte count comprised 51.1% neutrophils (CI ¼ 38.0%, 68.9%), 28.8% lymphocytes (CI ¼ 19.2%, 43.9%), 15.1% eosinophils (CI ¼ 5.7%,
33.3%) and <1% monocytes and basophils (Table 3). In comparison, leukocyte counts among cycling US women comprised
56.4% neutrophils (CI ¼ 41.9%, 76.7%), 30.7% lymphocytes
(CI ¼ 20.1%, 47.4%), 7.5% monocytes (CI ¼ 4.9%, 11.6%),
3.2% eosinophils (CI ¼ 1.2%, 7.1%) and <1% basophils
(Table 3 and Fig. 2).

Neutrophils. In both populations neutrophil proportions were
increasingly elevated by trimester, peaking at 71.8% (CI ¼
53.6%, 95.6%) among US women and 64.4% (CI ¼ 47.7%,
86.5%) among Tsimane women (Table 3 and Fig. 2). Across all
reproductive states, US women displayed greater neutrophil
proportions than Tsimane women (Table 3).

Lymphocytes. Pregnancy progression was associated with
declining lymphocyte proportions among both Tsimane and US

0.009
0.011
0.007
0.006
0.005
0.023
0.003
0.013
0.002
0.002
0.003
0.006
0.017
0.001
0.085

Parity
(0.007, 0.010)
(0.009, 0.013)
(0.006, 0.009)
(0.023, 0.011)
(0.000, 0.011)
(0.019, 0.026)
(0.001, 0.005)
(0.013, 0.014)
(0.001, 0.003)
(0.003, 0.000)
(0.005, 0.000)
(0.007, 0.004)
(0.012, 0.045)
(0.008, 0.010)
(0.077, 0.092)

0.004
0.009
0.000
0.003
0.009
0.056
0.033
0.036
0.005
0.004
0.017
0.021
0.002
0.004
0.036

(0.009, 0.001)
(0.016, 0.002)
(0.006, 0.006)
(0.028, 0.021)
(0.028, 0.047)
(0.051, 0.061)
(0.047, 0.021)
(0.041, 0.030)
(0.009, 0.002)
(0.002, 0.009)
(0.007, 0.027)
(0.031, 0.011)
(0.044, 0.042)
(0.057, 0.061)
(0.006, 0.078)

women, though Tsimane individuals exhibited higher lymphocyte proportions across all three trimesters. Lymphocyte percentages reached population-specific lows of 23.3% (CI ¼ 15.0%,
35.8%) for Tsimane women in the second trimester and 18.6%
(CI ¼ 12.3%, 29.1%) for US women in the third trimester
(Table 3 and Fig. 2).

Eosinophils. Later pregnancy was associated with reduced eosinophil proportions among the Tsimane, reaching a thirdtrimester low of 9.5% (CI ¼ 3.5%, 20.8%). Among US women,
pregnancy progression was associated with a comparatively
small decrease in eosinophil proportion, reaching a thirdtrimester low of 2.3% (CI ¼ 0.9%, 5.4%) (Table 3 and Fig. 2).

Monocytes and basophils. In both populations, basophil and
monocyte proportions were low and did not vary substantially
by reproductive state (Table 3 and Fig. 2).

Early pregnancy is associated with inflammatory activation
in both populations, but only US women retain elevated
inflammation in late pregnancy
Among cycling women, CRP concentration did not differ substantially across populations (Table 3). Among US women in
the first, second and third trimester, CRP was elevated by
169.0% (CI ¼ 105.9%, 244.7%), 247.2% (CI ¼ 184.6%, 318.0%)
and 137.7% (CI ¼ 98.0%, 184.2%), respectively (Table 4).
Among Tsimane women, CRP in the first and second trimester
was elevated by 180.7% (CI ¼ 46.1%, 436.6%) and 199.3% (CI
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Figure 1. Total leukocyte, neutrophil, lymphocyte, eosinophil, monocyte and basophil counts among Tsimane (blue) and US women (orange) in each reproductive state. Raw data are represented by density curves, while dots indicate model-estimated median values standardized by age, BMI and parity. C, nonpregnant cycling; T1, trimester 1; T2, trimester 2; T3, trimester 3. All y-axes are natural logged but are on different scales

¼ 65.1%, 447.3%), while third trimester CRP largely overlapped
with baseline concentrations (Table 4). Consequently, third trimester Tsimane women displayed CRP concentrations that
were, on average, 54.1% (CI ¼ 6.7%, 75.8%) or 1.89 mg/l (CI ¼
0.25, 2.85) lower than their third trimester US counterparts
(Table 3 and Fig. 3).

Reduced models excluding BMI and parity predict even
greater magnitude of population-level differences in total
leukocyte and neutrophil count and CRP concentration
To further evaluate the contribution of BMI and parity to
between-population differences in immune markers across reproductive states, we compared the predicted values for total
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Figure 2. Leukocyte proportions among Tsimane (blue) and US women (orange) across reproductive states. Raw data are represented by density curves, while
dots indicate model-estimated median values standardized by age, BMI and parity. C, non-pregnant cycling; T1, trimester 1; T2, trimester 2; T3, trimester 3

leukocyte, neutrophil, lymphocyte, eosinophil and monocyte
count and CRP concentration generated by our full models
(which included age, parity and BMI and trimester:population as
interaction term) with those produced by reduced models,
which omitted BMI and parity as covariates. Models excluding
BMI and parity predicted higher values for total leukocytes, neutrophils and CRP among US women and lower values for total
leukocyte and neutrophil counts among Tsimane individuals,
resulting in heightened estimated population-level differences
across reproductive states for these measures. Removing
effects of BMI and parity produced largely unchanged predicted
values for lymphocyte, eosinophil and monocyte counts
(Supplementary Table S1 and Fig. S1). Taken together, these
results indicate that the ‘true’ differences in total leukocyte and
neutrophil count and CRP between US and Tsimane women are
partially due to BMI and parity but cannot be fully explained by
these factors.

DISCUSSION
These results provide strong evidence that the immunology of
pregnancy, a unique physiological state involving exposure to
fetal antigens, consistently follows overarching patterns of
modulation across diverse human populations but is also influenced by local ecological conditions. Elevated leukocyte count,
currently considered a reliable clinical marker of pregnancy progression [17,36], was replicated in our US sample but was not
observed among Tsimane women, who exhibited high leukocyte
counts regardless of reproductive phase. Pregnancy was strongly associated with increased neutrophil counts, reduced lymphocytes and fewer eosinophils in both populations, suggesting
heavier reliance on non-specific immune defenses and downregulation of antigen-specific immunity across diverse

ecologies. However, although population-specific effects of
pregnancy on leukocyte subsets were in the same direction,
Tsimane women retained greater absolute and relative lymphocyte and eosinophil counts and showed lower absolute and relative neutrophil and monocyte prevalence, irrespective of
trimester. Acute systemic inflammation, measured by CRP, was
elevated among pregnant women in the first two trimesters in
both populations, which is consistent with previous reports
suggesting that pregnancy is a controlled state of inflammation
[17, 37]. Yet our results also indicate that, when compared to
US women, Tsimane women undergo relatively less change in
inflammatory activation across gestation, particularly in the
third trimester.
Absence of pregnancy-induced leukocytosis, comparatively
low neutrophil and monocyte counts, and relatively attenuated
acute inflammation among pregnant Tsimane women may be
due in part to strong constraints imposed by infection risk and
competing demands on energy distribution. Among the
Tsimane, 10% of all fetal deaths are attributed to maternal infection [38]. While there are surprisingly few data on the rate of
infection-induced miscarriages in the USA, many infectious diseases with the greatest impact on miscarriage risk (e.g. malaria,
Dengue fever) are endemic to the Amazonian region and relatively rare in high-income post-industrial contexts, suggesting
maternal infection poses a proportionally greater threat to pregnancy among the Tsimane [39, 40]. In addition, infection with
hookworm (an intestinal parasite endemic to the Amazon) is
associated with older age of first birth and reduced lifetime fertility among Tsimane women [33], possibly as a result of conflicting immunological demands during pregnancy [7].
Maintaining elevated immune activation and sustaining pregnancy are metabolically costly processes [29, 41], especially in
resource-restricted environments where infection risk is high
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Figure 3. CRP concentration among Tsimane (blue) and US women (orange) by reproductive status. Raw data are represented by density curves. Dots indicate model-estimated median values and error bars represent model-estimated 5th and 95th confidence intervals, all standardized for age, BMI and parity. C,
non-pregnant cycling; T1, trimester 1; T2, trimester 2; T3, trimester 3. y-Axis is natural logged

[42]. Under such constraints, Tsimane women may retain relatively greater investment in lymphocyte and eosinophil cell populations during pregnancy as a strategy to contend with
ongoing exposure to quickly evolving pathogens and parasitic
invaders [31], necessitating comparatively tempered neutrophil
and monocyte proliferation and systemic inflammation despite
potential costs (e.g. bacterial infections).
Another interpretation of our findings is that Tsimane women
may be, in certain aspects, better primed for pregnancy than
their US counterparts. While the Tsimane contend with high infectious disease morbidity and mortality, pathogen exposure
also provides benefits, namely finer immunological calibration
that safeguards against autoreactivity and hypersensitivity [8]. It
stands to reason that this protective effect extends to encounters with fetal antigens during pregnancy, thus dampening

responsivity—especially in terms of inflammatory processes.
Chronic infection with parasites that induce similar states of immunological tolerance may especially attune the maternal immune system for pregnancy [43]. Infection with roundworm
(Ascaris lumbricoides), a low-virulence intestinal parasite that stifles host inflammation, has already been linked to earlier age of
first reproduction and higher lifetime fertility among Tsimane
women [33], providing preliminary support for this perspective.
In contrast, exposure to fetal antigens may prompt exaggerated
and potentially deleterious inflammatory activation among
women in the USA, where opportunities for immune calibration
are comparatively scarce. This interpretation is bolstered by our
observation that acute systemic inflammation was higher
among US women in later pregnancy, a phase of gestation
marked by increasing exposure to cell-free fetal DNA [13].
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Comparatively elevated investment in neutrophils among pregnant US women could also indicate a greater skew toward inflammatory activation, considering neutrophils often initiate
and amplify inflammatory cascades [ 44]. However, pregnancyinduced neutrophil expansion could also be a compensatory
mechanism tempering responsivity to fetal antigens, considering neutrophils are also capable of inducing regulatory T cell
phenotypes during pregnancy [45].

Limitations and future directions
While our findings provide clear evidence that ecological variation impacts both non-pregnant immune profiles and immunological investment strategies during pregnancy, the
underlying causal pathways and consequences remain points of
speculation. Future research should employ longitudinal study
designs to definitively link variation in the expression of fetal tolerance with maternal and infant outcomes, as this approach
would allow for a better understanding of how much variation
stems from differences in immune calibration and how much
can be attributed to localized constraints and trade-offs. Given
that there are documented individual and population-level differences in placental morphology [46], with more invasive placentation associated with higher levels of cell-free fetal DNA
[47], it is theoretically possible that our findings could be related
to population-level differences in fetal antigen exposure stemming from differences in fetal size and/or placental phenotype.
To further explore this possibility, future studies would benefit
from a closer consideration of how levels of cell-free fetal DNA
and placental phenotype might affect maternal immune profiles, particularly across ecologically distinct populations. Along
a similar vein, we were not able to account for potential
population-level differences in hematological parameters (e.g.
blood viscosity, plasma volume), which have been found to vary
across other ecological clines (e.g. high versus low altitude)
[48]. Considering increased blood viscosity during pregnancy
could place functional limits on the number of circulating immune cells, documenting and accounting for hematological
profile would be a useful addition to future studies. Subsequent
research would also benefit from evaluating the effects of pregnancy and environment on a wider breadth of immune biomarkers. Due to dataset restrictions, we were limited to
quantifying large-scale differences in immune cell populations
and a singular measure of acute inflammation (with a small
THLHP sample size), excluding other relevant and more finegrained indices of immune function (e.g. cytokine profiles, proportion of regulatory T cells, neutrophil oxidative bursts). Lastly,
while the ecological landscape currently inhabited by Tsimane
women presumably more closely resembles the environmental
conditions that prevailed before the agricultural transition and
industrialization, the Tsimane do not serve as a universal
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representation of other past or contemporary non-industrialized
populations. Rather, this study highlights the need for future
studies to consider variation both across and within nonindustrialized contexts, especially since myriad factors combine
to produce mosaic ecologies. The USA itself encompasses
underappreciated and understudied disparity in environmental
circumstances; numerous so-called ‘Third World’ diseases remain endemic in certain rural areas [49] and disproportionately
affect marginalized communities within urban centers [50].
Future research on populations where infectious disease burden remains elevated but where the immunoregulatory benefits
are obscured by processed diets, physical inactivity and other
adverse consequences of ‘modernization’ may yield particularly
fruitful insight into how interactions between environmental
factors influence maternal immune profiles across reproductive
states.

CONCLUSIONS AND IMPLICATIONS
To our knowledge, this is the first study to estimate the effects
of pregnancy on female immune status in a non-industrialized
context and the first to directly compare expressions of fetal tolerance between two ecologically distinct populations. Our
results replicate previous findings that pregnancy is not a state
of immunosuppression, but rather a period of dynamic immune
modulation generally favoring non-specific defenses and downregulated antigen-specific immunity and parasite response.
While these overarching patterns appear to be shared across
populations, this study provides evidence that immunological
profiles during pregnancy vary in response to ecology, with
pregnant Tsimane women exhibiting comparatively elevated investment in lymphocyte and eosinophil cell populations, relatively smaller neutrophil and monocyte counts, and attenuated
acute inflammatory activation. These findings likely reflect steep
trade-offs between fetal tolerance, pathogen defense and energy
restriction among the Tsimane, but could also indicate that
Tsimane women benefit from comparatively reduced inflammatory activation and stronger resistance to intracellular pathogens across gestation. Future research is needed to parse out
the potential benefits of pathogen exposure in moderating
responses to fetal antigens and the constraints imposed by ongoing disease risk and resource budgeting. While such questions remain, this study is an important first step in
acknowledging that the immunology of successful pregnancy is
not a one-size-fits-all phenomenon. In sum, our findings add
nuance to the current understanding of ‘normal’ pregnancy and
will hopefully prompt further consideration of ecological variability both across and within populations, especially as it pertains to maternal health and disease.
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